WUXI BIO (02269) spent approximately 49.889 million Hong Kong dollars to repurchase 1.512 million shares on June 3rd.
WuXi Biologics (02269) announced on June 3, 2026 that it plans to repurchase 1.512 million shares of its own stock at a cost of approximately HK$49.889 million.
WUXI BIO (02269) announced on June 3, 2026 that it spent approximately HK$49.889 million to repurchase 1.512 million shares.
Related Articles
JST GROUP (06687) bought back 245,000 shares at a cost of HK$4.4276 million on June 3rd.
Dajin Heavy Industry (01081): The offering price is set at HK$66.40 per share of H Shares.
US Stock Market Move | Marvell Technology, Inc. (MRVL.US) opened and continued to rise by over 6%, with a total increase of over 260% for the year.
JST GROUP (06687) bought back 245,000 shares at a cost of HK$4.4276 million on June 3rd.
Dajin Heavy Industry (01081): The offering price is set at HK$66.40 per share of H Shares.
US Stock Market Move | Marvell Technology, Inc. (MRVL.US) opened and continued to rise by over 6%, with a total increase of over 260% for the year.
